#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén

About this episode

Niklas Norén discusses the integration of artificial intelligence in pharmacovigilance and its implications for drug safety.

Send a text message to the show! Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing trust and where do we set the limits? In this two-part episode, Niklas Norén, head of Research at Uppsala Monitoring Centre, unpacks how artificial intelligence can add value to pharmacovigi...

People in this episode

Guest: Niklas Norén

Topics covered

• artificial intelligence
• pharmacovigilance
• drug safety
• signal detection

Keywords

• generative AI
• trust
• case processing

More episodes of Drug Safety Matters

• #46 Protecting the health ecosystem – Valentina Giunchi & Joe Mitchell · June 4, 2026 · 35 min
• #45 How to perform better disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek · March 26, 2026 · 47 min
• #44 Rethinking medical device safety, part 2 – Omar Aimer · February 26, 2026 · 21 min
• #43 Rethinking medical device safety, part 1 – Omar Aimer · January 28, 2026 · 23 min
• #42 Unpacking the WHO Global Smart Pharmacovigilance Strategy – Shanthi Pal · December 16, 2025 · 19 min
• #40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén · October 17, 2025 · 30 min